CBC
image from IGSB

Seminars

Upcoming Seminars

Please, see Events for a complete list of upcoming courses, seminars, workshops, symposia and other events.

 

Archives

CBC Seminar: Nobel Prizes and Nucleic Acids: A Drama in Five Acts

Date: June 10, 2010
Time: 4:00 PM - 5:00 PM
Speaker: Dr. Erling Norrby
Professor of Virology, Center for History of Science, The Royal Swedish Academy of Sciences, Stockholm, Sweden
Location: Abbott Auditorium, Pancoe-NSUHS Pavilion, Northwestern University - Evanston Campus, 2200 Campus Drive, Evanston, IL 60208

Dr. Norby, a member of the Board of the Nobel Foundation (1997-2003) is the author of a forthcoming book: “Nobel Prizes and Life Sciences”.

(view poster) (more info)

(back to the top) 

 

The Translational Technologies and Resources Core Seminar Series (UIC):
"Top Down Mass Spectrometry: Has Its Decade Now Come? "

Date: February 8, 2010
Time: 12:30 PM - 1:30 PM
Speaker: CBC Investigator - Neil Kelleher, Ph.D.
Professor of Chemistry, University of Illinois—Urbana/Champaign & (May 2010) Senior Chair in the Sciences, Feinberg School of Medicine, Northwestern University
Location: College of Medicine Research Building, 909 S. Wolcott, 2nd Floor, Conference Room 2175, University of Illinois at Chicago.

(more info)

(back to the top) 

 

The CBC/IGSB Seminar: High-Throughput Cellular Screening

Time: December 15, 2008, 10:00am-12:00pm
Location: Northwestern University
Cook Hall, room 3118
2220 Campus Dr, Evanston, IL 60208

Presentations included an overview of the mission of the IGSB's Cellular Screening Center (CSC) and a description of CSC resources and technologies. The CSC facilitates drug discovery and development by defining the complex genetics underlying disease, isolating chemical compounds that affect specific cellular activities, and developing potential therapeutics to target disease pathways (for more information please visit http://www.igsb.org).

(back to the top) 

 

"Statistical Considerations on the Process of Discovering and Validating Biomarker Candidates Using Mass Spectrometry Platforms"

Speaker: Cliff Spiegelman, Ph.D., Professor of Statistics, Texas A & M University
Time: Friday, May 25, 2007, 3:00 P.M. – 4:00 P.M.
Location: Northwestern University (Evanston Campus)
CBC Cook Hall Access Grid Site, Cook Hall, Room: 3118
2220 Campus Drive, Evanston

Abstract: Claims have been made that the application of supervised pattern recognition methodology can be used with mass spectrometry (MS) proteomic data to achieve near perfect sensitivity and specificity for detecting early stage cancer. So far those claims have not been verified partly due to the use of less than optimal experimental design. In the interim significant effort has been spent on proteomic biomarker discovery research (without significant positive results) largely using tandem MS platforms. Underpinning the proteomics studies are several key components including standardization of materials, bioinformatics, reagent development, MS improvements, and statistics. This presentation discusses the National Cancer Institute's Clinical Proteomic Technology Assessment for Cancer and a related study, focusing on the statistical design of experiment input.

(back to the top)